RRN3P1

Across TCGA pan-cancer cohorts, RRN3P1 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated RRN3P1 data layer compared with 20 for mass-spec protein.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RRN3P1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated RRN3P1 expression acts as an unfavorable survival marker.

HNSC and THYM are the cancer types where RRN3P1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Median	III,IV	0.021	0.726	<.001	30	view →
THYM	DFS	Median	II,III,IV	0.145	0.873	<.001	12	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

RRN3P1–HNSC (OS)

Open the HNSC breakdown →